ProAssurance (PRA) Projected to Post Earnings on Monday

ProAssurance (NYSE:PRA) will likely be posting its quarterly earnings results after the market closes on Monday, February 24th. Analysts expect ProAssurance to post earnings of $0.17 per share and revenue of $274.56 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

ProAssurance Stock Performance

Shares of NYSE PRA opened at $13.99 on Friday. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance has a 12 month low of $10.76 and a 12 month high of $17.79. The company has a 50 day simple moving average of $15.24 and a two-hundred day simple moving average of $14.95. The stock has a market cap of $715.47 million, a price-to-earnings ratio of 16.85 and a beta of 0.27.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. StockNews.com raised shares of ProAssurance from a “hold” rating to a “buy” rating in a report on Thursday, December 26th. Truist Financial lifted their target price on shares of ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, November 12th. Finally, Piper Sandler lowered shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 target price for the company. in a report on Monday, November 11th.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.